Publication:
Recommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines.

cris.virtual.author-orcid0000-0002-3813-4616
cris.virtualsource.author-orcid54d0c66e-7d5f-4150-b6d9-7ac884e603a0
cris.virtualsource.author-orcidd7590ac9-7872-44f9-8943-3571b0963df5
datacite.rightsopen.access
dc.contributor.authorvan der Ploeg, Milly A
dc.contributor.authorFloriani, Carmen
dc.contributor.authorAchterberg, Wilco P
dc.contributor.authorBogaerts, Jonathan M K
dc.contributor.authorGussekloo, Jacobijn
dc.contributor.authorMooijaart, Simon P
dc.contributor.authorStreit, Sven
dc.contributor.authorPoortvliet, Rosalinde K E
dc.contributor.authorDrewes, Yvonne M
dc.date.accessioned2024-10-28T17:32:03Z
dc.date.available2024-10-28T17:32:03Z
dc.date.issued2020-02
dc.description.abstractOBJECTIVES As a person's age increases and his/her health status declines, new challenges arise that may lead physicians to consider deprescribing statins. We aimed to provide insight into recommendations available in international cardiovascular disease prevention guidelines regarding discontinuation of statin treatment applicable to older adults. DESIGN We systematically searched PubMed, EMBASE, EMCARE, and the websites of guideline development organizations and online guideline repositories for cardiovascular disease prevention guidelines aimed at the general population. We selected all guidelines with recommendations (instructions and suggestions) on discontinuation of statin treatment applicable to older adults, published between January 2009 and April 2019. In addition, we performed a synthesis of information from all other recommendations for older adults regarding statin treatment. Methodological quality of the included guidelines was appraised using the appraisal of guidelines for research & evaluation II (AGREE II) instrument. RESULTS Eighteen international guidelines for cardiovascular disease prevention in the general adult population provided recommendations for statin discontinuation that were applicable to older adults. We identified three groups of instructions for statin discontinuation related to statin intolerance, and none was specifically aimed at older adults. Three guidelines also included suggestions to consider statin discontinuation in patients with poor health status. Of the 18 guidelines included, 16 made recommendations regarding statin treatment in older adults, although details on how to implement these recommendations in practice were not provided. CONCLUSION Current international cardiovascular disease prevention guidelines provide little specific guidance for physicians who are considering statin discontinuation in older adults in the context of declining health status and short life expectancy.
dc.description.numberOfPages9
dc.description.sponsorshipBerner Institut für Hausarztmedizin (BIHAM)
dc.identifier.doi10.7892/boris.134613
dc.identifier.pmid31663610
dc.identifier.publisherDOI10.1111/jgs.16219
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/182984
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofJournal of the American Geriatrics Society
dc.relation.issn0002-8614
dc.relation.organizationDCD5A442BDB9E17DE0405C82790C4DE2
dc.subjectcardiovascular diseases clinical decision making drug therapy hydroxymethylglutaryl-CoA reductase inhibitors prevention
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc300 - Social sciences, sociology & anthropology::360 - Social problems & social services
dc.titleRecommendations for (Discontinuation of) Statin Treatment in Older Adults: Review of Guidelines.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage425
oaire.citation.issue2
oaire.citation.startPage417
oaire.citation.volume68
oairecerif.author.affiliationBerner Institut für Hausarztmedizin (BIHAM)
oairecerif.author.affiliationBerner Institut für Hausarztmedizin (BIHAM)
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2020-03-03 08:39:48
unibe.description.ispublishedpub
unibe.eprints.legacyId134613
unibe.journal.abbrevTitleJ AM GERIATR SOC
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
vanderPloeg JAmGeriatrSoc 2020.pdf
Size:
419.38 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by-nc/4.0
Content:
published

Collections